Thursday September 28, 2023
  • |Subscribe
  • |Contribute
  • |About
  • |Access Your Account
  • |Register
  • |Login
  • |Home
  • |Issue Archive
    • |Featured Reports
    • |eBooks
  • |BioProcess Insider
  • |Multimedia
    • |BPI White Papers
    • |Webinars
    • |Posters
  • |BioProcess International Events
    • |BioProcess International Conference & Exhibition
    • |Cell & Gene Therapy Manufacturing & Commercialization US
    • |Well Characterized Biologics & Biological Assays
    • |Cell & Gene Therapy Manufacturing & Commercialization Europe
  • |BioProcess International Academy
  • |Events

BioProcess International

Covering the whole development process for the global biotechnology industry

  • Upstream
    Processing
    Bioprocessing begins upstream, most often with culturing of animal or microbial cells in a range of vessel types (such as bags or stirred tanks) using different controlled feeding, aerating, and process strategies.
    • Assays
    • Biochemicals/Raw Materials
    • Bioreactors
    • Cell Culture Media
    • Expression Platforms
    • Fermentation
    • Perfusion Cell Culture
    • Upstream Contract Services
    • Upstream Single-Use Technologies
  • Downstream
    Processing
    Beginning with harvest of material from a bioreactor, downstream processing removes or reduces contaminants to acceptable levels through several steps that typically include centrifugation, filtration, and/or chromatographic technologies.
    • Filtration
    • Separation/Purification
    • Viral Clearance
    • Chromatography
    • Downstream Contract Services
    • Downstream Single-Use Technologies
  • Manufacturing
    Drug products combine active pharmaceutical ingredients with excipients in a final formulation for delivery to patients in liquid or lyophilized (freeze-dried) packaged forms — with the latter requiring reconstitution in the clinical setting.
    • Biosimilars
    • Cell/Gene Therapies
    • Continuous Bioprocessing
    • Emerging Therapeutics
    • Facility Design/Engineering
    • Fill/Finish
    • Formulation
    • Information Technology
    • MAb
    • Manufacturing Contract Services
    • Personalized Medicine
    • Process Monitoring and Controls
    • Single Use
    • Supply Chain
    • Vaccines
    • Validation
  • Analytical
    Many technologies are used to characterize biological products, manufacturing processes, and raw materials. The number of options and applications is growing every day — with quality by design (QbD) giving impetus to this expansion.
    • Culture Development
    • Cell Line Development
    • Downstream Development
    • Downstream Validation
    • Laboratory Equipment
    • PAT
    • Pre-Formulation
    • Product Characterization
    • QA/QC
    • Upstream Development
    • Upstream Validation
    • Leachables/Extractables/Particulates
  • Business
    Even as it matures, the biopharmaceutical industry is still a highly entrepreneurial one. Partnerships of many kinds — from outsourcing to licensing agreements to consultancies — help companies navigate this increasingly global business environment.
    • Careers
    • CMC Forums
    • Economics
    • Intellectual Property
    • Pre-Clinical and Clinical Trials
    • Regulatory Affairs
    • Risk Management
    • BioRegions

March 2007 Supplement

Advances in Separation Methods for Increasing Process Streams

by BPI Contributor
March 1, 2007

Genetic Engineering Leads to Microbial, Animal Cell, and Transgenic Expression Systems

by BPI Contributor
March 1, 2007

In Operations, It’s All About Excellence

by BPI Contributor
March 1, 2007

Increasing Sophistication in Licensing

by BPI Contributor
March 1, 2007

IP Business and Protection

by BPI Contributor
March 1, 2007

Many Pathways for Discovery

by BPI Contributor
March 1, 2007

New Ideas. Bold Ventures. Global Benefits.

by BPI Contributor
March 1, 2007

Offshoring to Asia

by BPI Contributor
March 1, 2007

Regulatory Compliance for Product Quality, Safety, and Efficacy

by BPI Contributor
March 1, 2007

Spread of Clinical Trials Spurs CRO Use and IT Adaptation

by BPI Contributor
March 1, 2007
  • 1
  • 2
  • >

  • BioProcess Insider

    CPHI report: China develops own biologics niche; no longer low-cost manufacturer

  • BioProcess Insider

    It’s not me, it’s you! Experts on when you should dump your CDMO

  • Sponsored Content

    Accelerate your cell and gene therapeutic pipeline with IDT Biologika’s AAV & LVV platforms

  • BioProcess Insider

    BWB 2023: Timelines, tech, trust critical to CDMO management success

  • BioProcess Insider

    Moderna scaling back manufacturing network post-COVID

  • Sponsored Content

    Managing Complex Considerations With Pharmaceutical Facility Design


BioProcess International BIO Theater

Recent Tweets

  • Tweet Avatar Please join us for a #BPIAskTheExpert on "Development of IEX Purification Process for Lentiviral Vectors." Date: T… https://t.co/vgK15PE2rB 4 months ago
  • Tweet Avatar Please join us for a #BPIAskTheExpert on "Innovation of Novel Purification Strategies – A Case Study of a Clusterin… https://t.co/7jyYh7UsoM 4 months ago
  • Tweet Avatar Please join us for a #BPIAskTheExpert on "Innovation of Novel Purification Strategies – A Case Study of a Clusterin… https://t.co/zokTnEdk6F 4 months ago
  • Tweet Avatar Please join us for a #BPIAskTheExpert on "Innovation of Novel Purification Strategies – A Case Study of a Clusterin… https://t.co/lR7nAmnryf 4 months ago
Follow @bioprocessintl

Explore Topics

  • Upstream Processing
  • Downstream Processing
  • Manufacturing
  • Analytical
  • Business

Publication

  • Issue Archive
  • Featured Reports
  • eBooks
  • Subscribe
Connect
Privacy policy

BioProcessIntl.com

  • White Papers
  • Posters
  • Webinars
  • BPI Theater
  • Awards
  • Register
  • Login
  • Access Your Account

Keep up with BPI

  • Email Newsletters
  • Events
  • BioProcess Insider
  • Twitter
  • LinkedIn

About BPI

  • Who We Are
  • Editorial Advisors
  • Author Guidelines
  • Advertising/Media Kit
  • List Rental/Reprints
  • Contact Us
  • Careers
BPI
twitter linkedin
Site Map|Contact
©2023 BioProcess International All Rights reserved
  • Home
  • Issue Archive
    â–¼
    • Featured Reports
    • eBooks
  • BioProcess Insider
  • Multimedia
    â–¼
    • BPI White Papers
    • Webinars
    • Posters
  • BioProcess International Events
    â–¼
    • BioProcess International Conference & Exhibition
    • Cell & Gene Therapy Manufacturing & Commercialization US
    • Well Characterized Biologics & Biological Assays
    • Cell & Gene Therapy Manufacturing & Commercialization Europe
  • BioProcess International Academy
  • Events